In the last decade, interest in the field of three-dimensional (3D) bioprinting has increased
enormously. 3D bioprinting combines the fields of developmental biology, stem cells, and …

Successful launch of a commercial drug requires significant investment of time and financial
resources wherein late-stage failures become a reason for catastrophic failures in drug …

We present a new strategy for the fabrication of artificial skeletal muscle tissue with
functional morphologies based on an innovative 3D bioprinting approach. The methodology …

Improving the ability to predict the efficacy and toxicity of drug candidates earlier in the drug
discovery process will speed up the introduction of new drugs into clinics. 3D in vitro …

Osteochondral (OC) repair is an extremely challenging topic due to the complex biphasic
structure and poor intrinsic regenerative capability of natural osteochondral tissue. In …

Given the limited spontaneous repair that follows cartilage injury, demand is growing for
tissue engineering approaches for cartilage regeneration. There are two major applications …

Introduction: Biomaterial-based scaffold formulations (three-dimensional Porous matrix,
nano-fibre mesh, hydrogels and microspheres) are the major components that are used to …

Drug discovery is an expensive and lengthy process. Among the different phases, drug
discovery and preclinical trials play an important role as only 5–10 of all drugs that begin …

Defects of articular cartilage present a unique clinical challenge due to its poor self-healing
capacity and avascular nature. Current surgical treatment options do not ensure consistent …

Skeletal muscle regeneration is one of the major areas of interest in sport medicine as well
as trauma centers. Three‐dimensional (3D) bioprinting (BioP) is nowadays widely adopted …